AAAAAA

   
Results: 1-8 |
Results: 8

Authors: RAZA A ALVI S BOROK RZ SPAN L PARCHARIDOU A ALSTON D RIFKIN S ROBIN E SHAH R GREGORY SA
Citation: A. Raza et al., EXCESSIVE PROLIFERATION MATCHED BY EXCESSIVE APOPTOSIS IN MYELODYSPLASTIC SYNDROMES - THE CAUSE-EFFECT RELATIONSHIP, Leukemia & lymphoma, 27(1-2), 1997, pp. 111-118

Authors: RAZA A ALVI S BROADYROBINSON L SHOWEL M CARTLIDGE J MUNDLE SD SHETTY VT BOROK RZ DAR SE CHOPRA HK SPAN L PARCHARIDOU A HINES C GEZER S VENUGOPAL P LOEW J SHOWEL J ALSTON D HERNANDEZ B RIFKIN S ROBIN E SHAH R GREGORY SA
Citation: A. Raza et al., CELL-CYCLE KINETIC-STUDIES IN 68 PATIENTS WITH MYELODYSPLASTIC SYNDROMES FOLLOWING INTRAVENOUS IODODEOXYURIDINE AND OR BROMODEOXYURIDINE/, Experimental hematology, 25(6), 1997, pp. 530-535

Authors: RAZA A MUNDLE S SHETTY V ALVI S CHOPRA H SPAN L PARCHARIDOU A DAR S VENUGOPAL P BOROK R GEZER S SHOWEL J LOEW J ROBIN E RIFKIN S ALSTON D HERNANDEZ B SHAH R KAIZER H GREGORY S
Citation: A. Raza et al., NOVEL INSIGHTS INTO THE BIOLOGY OF MYELODYSPLASTIC SYNDROMES - EXCESSIVE APOPTOSIS AND THE ROLE OF CYTOKINES, International journal of hematology, 63(4), 1996, pp. 265-278

Authors: RAZA A MUNDLE S SHETTY V ALVI S CHOPRA H SPAN L PARCHARIDOU A DAR S VENUGOPAL P BOROK R GEZER S SHOWEL J LOEW J ROBIN E RIFKIN S ALSTON D HERNANDEZ B SHAH R KAIZER H GREGORY S PREISLER H
Citation: A. Raza et al., A PARADIGM SHIFT IN MYELODYSPLASTIC SYNDROMES, Leukemia, 10(10), 1996, pp. 1648-1652

Authors: RAZA A DAR S GEZER S GREGORY S VENUGOPAL P HINES C MUNDLE S SHETTY V SPAN L CHOPRA H ALVI S BOROK R ROBIN E RIFKIN S ALSTON D HERNANDEZ B HSU WT PREISLER H
Citation: A. Raza et al., THE STEM-CELL DISORDER IN MYELODYSPLASTIC SYNDROMES IS FURTHER CONFOUNDED BY COMPLEX CYTOKINE EFFECTS IN A STUDY OF 109 PATIENTS, Experimental hematology, 24(9), 1996, pp. 307-307

Authors: SHETTY V DAR S HUSSAINI S ALVI S SPAN L MUNDLE S GEZER S GREGORY S VENUGOPAL P HINES C CHOPRA H BOROK R ROBIN E RIFKIN S ALSTON D HERNANDEZ B HSU WT PREISLER H RAZA A
Citation: V. Shetty et al., EFFECT OF ANTI-PHOSPHATIDIC DRUGS ON THE EXPRESSION OF CYTOKINES IN MYELODYSPLASTIC SYNDROMES (MDS), Experimental hematology, 24(9), 1996, pp. 573-573

Authors: SPAN L SHETTY V BROADYROBINSON L MUNDLE SD ALVI S BOROK R REZA S DAR S BOUKHRIS T KUMAR R VENUGOPAL P GEZER S ROBIN E RIFKIN S HINES C RAZA A
Citation: L. Span et al., CD34-VIVO LABELING INDEX (LI) THAN CD34 NEGATIVE CELLS IN MYELODYSPLASTIC SYNDROMES (MDS)( CELLS HAVE A LOWER IN), Blood, 88(10), 1996, pp. 365-365

Authors: RAZA A GEZER S GREGORY SA VENUGOPAL P KAIZER H DONG LM SPAN L HINES C THOMAS R ALVI S MUNDLE SD SHETTY V BOREK R LOEW J REZA S ROBIN EL RIFKIN SD ALSTON D HERNANDEZ BM SHAH R HSU WT DAR S PREISLER HD
Citation: A. Raza et al., ANTI-CYTOKINE THERAPY PRODUCES RESPONSE IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS), Blood, 88(10), 1996, pp. 2310-2310
Risultati: 1-8 |